Accurately measure the pharmacokinetics (PK) and immunogenicity of your biotherapeutics and advanced modalities including cell and gene therapies
We provide the global, best-in-class bioanalytical capabilities needed to address even the most challenging PK, ADA, and neutralizing antibody assay requirements.
Detect your drug product and it’s downstream effects with an experienced molecular assay partner
We have a proven track record working with biotherapeutics and advanced modalities. We have been successfully supporting these programs across a variety of delivery mechanisms and matrices for over 10 years.
Access our vast biomarker experience to better understand the PD of your therapeutic
We offer a wide variety of off-the-shelf biomarker assays, including 120+ validated biomarker assays for a range of disease states as well as experience in developing novel PD assays.
Rely on services backed by global good manufacturing practices (GMP)
We offer a full suite of bioanalytical lifecycle services supporting the release, production, and manufacturing of therapeutic drugs. Our GMP-driven service offerings include immunoassays, cell-based assays, and molecular assays for potency assessments.